Page last updated: 2024-08-21

isoxazoles and Polymyalgia Rheumatica

isoxazoles has been researched along with Polymyalgia Rheumatica in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Diamantopoulos, AP; Hetland, H; Myklebust, G1
Braunert, L; Bruegel, M; Niederwieser, D; Pfrepper, C; Thiery, J1
Adizie, T; Borg, F; Christidis, D; Dasgupta, B; Dharmapaliah, C1

Other Studies

3 other study(ies) available for isoxazoles and Polymyalgia Rheumatica

ArticleYear
Leflunomide as a corticosteroid-sparing agent in giant cell arteritis and polymyalgia rheumatica: a case series.
    BioMed research international, 2013, Volume: 2013

    Topics: Adrenal Cortex Hormones; Aged; Female; Giant Cell Arteritis; Giant Cells; Humans; Isoxazoles; Leflunomide; Male; Middle Aged; Polymyalgia Rheumatica

2013
[Rituximab in the treatment of acquired haemophilia A in a patient with polymyalgia rheumatica].
    Hamostaseologie, 2010, Volume: 30 Suppl 1

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Hemophilia A; Humans; Isoxazoles; Leflunomide; Male; Polymyalgia Rheumatica; Prednisone; Rituximab; Treatment Outcome

2010
Efficacy and tolerability of leflunomide in difficult-to-treat polymyalgia rheumatica and giant cell arteritis: a case series.
    International journal of clinical practice, 2012, Volume: 66, Issue:9

    Topics: Aged; Aged, 80 and over; Antirheumatic Agents; Case-Control Studies; Female; Giant Cell Arteritis; Humans; Immunosuppressive Agents; Isoxazoles; Leflunomide; Male; Middle Aged; Polymyalgia Rheumatica; Prospective Studies; Recurrence; Treatment Outcome

2012